ABBV - AbbVie Inc.

NYSE - NYSE Delayed Price. Currency in USD

Cash Flow

Annual
All numbers in thousands
Period Ending12/31/201812/31/201712/31/201612/31/2015
Net Income5,687,0005,309,0005,953,0005,144,000
Operating Activities, Cash Flows Provided By or Used In
Depreciation1,765,0001,501,0001,189,000836,000
Adjustments To Net Income7,101,0003,141,0001,588,0001,051,000
Changes In Accounts Receivables-591,000-391,000-71,000-1,076,000
Changes In Liabilities190,000425,000-1,187,0001,503,000
Changes In Inventories-226,00093,000-38,000-434,000
Changes In Other Operating Activities-499,000-118,000-393,000511,000
Total Cash Flow From Operating Activities13,427,0009,960,0007,041,0007,535,000
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures-638,000-529,000-479,000-532,000
Investments368,000563,000-2,956,00048,000
Other Cash flows from Investing Activities--118,000118,000
Total Cash Flows From Investing Activities-1,006,000-274,000-6,074,000-12,936,000
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid-5,580,000-4,107,000-3,717,000-3,294,000
Sale Purchase of Stock----
Net Borrowings3,229,000-2,0005,594,00016,623,000
Other Cash Flows from Financing Activities-104,000-247,000-40,000-146,000
Total Cash Flows From Financing Activities-14,396,000-5,512,000-3,928,0005,752,000
Effect Of Exchange Rate Changes-39,00029,000-338,000-300,000
Change In Cash and Cash Equivalents-2,014,0004,203,000-3,299,00051,000